Feline Polycystic Kidney Disease: Welfare Management

Polycystic kidney disease is a hereditary condition common in Persian cats that progressively destroys kidney function and causes chronic suffering.

Key Facts

PKD affects approximately 40% of Persian cats and their crosses
Cysts are present from birth and grow slowly over years, eventually displacing normal kidney tissue
Clinical signs of kidney failure typically emerge at 7-10 years of age
A dominant mutation in the PKD1 gene is responsible for over 99% of feline PKD cases
DNA testing can identify carriers before breeding, enabling elimination from breeding populations

Welfare Considerations

Chronic kidney disease secondary to PKD causes sustained suffering including nausea, inappetence, lethargy, dehydration, and hypertension. Cats hide illness until disease is advanced, meaning many live with unrecognized chronic pain. Welfare-centered management includes subcutaneous fluid therapy, phosphate restriction, anti-nausea medication, and antihypertensives. Regular monitoring allows timely escalation of care and humane euthanasia decisions before quality of life deteriorates severely.

What You Can Do

Test breeding Persians for PKD1 mutation before reproduction
Adopt only from breeders who provide DNA-negative health certificates
Schedule annual kidney function panels for Persian cats from age 5
Contact Persian Cat Society to support breed-wide PKD elimination programs